Heart failure in China: epidemiology and current management
- PMID: 38973826
- PMCID: PMC11224652
- DOI: 10.26599/1671-5411.2024.06.008
Heart failure in China: epidemiology and current management
Abstract
The Annual Report on Cardiovascular Health and Diseases in China (2022) intricate landscape of cardiovascular health in China. In connection with the previous section, this sixth section of the report offers a comprehensive analysis of heart failure (HF) in China. HF is one of the most important cardiovascular disease in the 21st century. Its mortality is equivalent to that of cancer. It is an important public health problem that seriously affects the health of Chinese residents. In recent years, with the deepening of understanding, the change of treatment principles, the innovation of treatment methods and the update of treatment guidelines, the in-hospital mortality of HF patients has declined, and the long-term prognosis is also improving. However, there are still differences in the management level of HF among different hospitals in China. How to improve the standardized diagnosis and treatment level of HF in China remains an important challenge.
© 2024 JGC All rights reserved; www.jgc301.com.
Figures





Similar articles
-
Understanding the economic burden of heart failure in China: impact on disease management and resource utilization.J Med Econ. 2017 May;20(5):549-553. doi: 10.1080/13696998.2017.1297309. Epub 2017 Mar 12. J Med Econ. 2017. PMID: 28286996
-
Epidemiology and current management of cerebrovascular disease in China.J Geriatr Cardiol. 2024 May 28;21(5):465-474. doi: 10.26599/1671-5411.2024.05.009. J Geriatr Cardiol. 2024. PMID: 38948893 Free PMC article.
-
Pulmonary embolism and deep venous thrombosis in China.J Geriatr Cardiol. 2024 Aug 28;21(8):775-778. doi: 10.26599/1671-5411.2024.08.007. J Geriatr Cardiol. 2024. PMID: 39308502 Free PMC article.
-
Heart failure in China: a review of the literature.Drugs. 2013 May;73(7):689-701. doi: 10.1007/s40265-013-0057-8. Drugs. 2013. PMID: 23625274 Review.
-
Heart failure in sub-Saharan Africa: A clinical approach.S Afr Med J. 2016 Jan;106(1):23-31. doi: 10.7196/samj.2016.v106i1.10325. S Afr Med J. 2016. PMID: 26933706 Review.
Cited by
-
Role of metabolic dysfunction-associated fatty liver disease in atrial fibrillation and heart failure: molecular and clinical aspects.Front Cardiovasc Med. 2025 Apr 8;12:1573841. doi: 10.3389/fcvm.2025.1573841. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40264510 Free PMC article. Review.
-
Association between inflammatory burden index and risk of heart failure: evidence from NHANES 2003-2017.BMC Cardiovasc Disord. 2025 Apr 24;25(1):318. doi: 10.1186/s12872-025-04781-x. BMC Cardiovasc Disord. 2025. PMID: 40275161 Free PMC article.
-
The Role of Artificial Intelligence in the Prediction, Diagnosis, and Management of Cardiovascular Diseases: A Narrative Review.Cureus. 2025 Mar 28;17(3):e81332. doi: 10.7759/cureus.81332. eCollection 2025 Mar. Cureus. 2025. PMID: 40291312 Free PMC article. Review.
-
Association between social frailty and quality of life in older patients with chronic heart failure: sequential multiple mediating effects of family insufficiency and social networks.Front Med (Lausanne). 2025 Jul 22;12:1639935. doi: 10.3389/fmed.2025.1639935. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40766072 Free PMC article.
References
-
- Gu DF, Huang GY, Wu XG, et al [Epidemiological survey of heart failure in China and its prevalence] Zhonghua Xin Xue Guan Bing Za Zhi. 2003;31:6–9.
-
- Cheng KA, Wu N [Retrospective investigation of hospitalized chronic heart failure cases in certain regions of China in 1980, 1990, and 2000] Zhonghua Xin Xue Guan Bing Za Zhi. 2002;8:5–9.
-
- Pei ZY, Zhao YS, Li JY, et al [Fifteen-year changes in the etiology and short-term prognosis of hospitalized patients with chronic heart failure] Zhonghua Xin Xue Guan Bing Za Zhi. 2011;5:434–439. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous